Drug & Supplement Interactions

Terminalia + tipranavir

Brand name of tipranavir

  • Aptivus

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

Theoretically, use of Terminalia arjuna may increase the levels and clinical effects of CYP2D6 substrates. Of the 3 interaction records for this pair, the most serious is rated moderate.

This also applies to Aptivus, a brand name of tipranavir.

Read the Full Interaction Report

Dr. Brian Staiger’s Quick Take

Terminalia arjuna may raise tipranavir (Aptivus) levels, which could bring more nausea, stomach upset, diarrhea, or liver strain, though this is based only on lab studies. Ask your pharmacist or doctor before you add Terminalia.

Read his full note1-minute read
Moderate
Possible
3
D

Ask a Question About This Combination

Ask in your own words about taking Terminalia with tipranavir. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Terminalia and tipranavir Interaction

3 interaction records apply to these two. Each one is explained separately below.

Why Are There 3 Interaction Records?

We file Terminalia’s interactions under single medicines and under categories of medicines that share an effect. tipranavir is named in, or belongs to, 3 of them, so 3 records apply. They can describe the same effect, so they are not 3 separate risks. We’ve listed each one below; the most serious of them (Moderate) sets the overall rating.

Moderate Interaction 1 of 3

Terminalia With Cytochrome P450 2D6 (CYP2D6) Substrates

Why this applies to tipranavir

  1. The SupplementTerminalia
  2. Interacts With the CategoryCytochrome P450 2D6 (CYP2D6) Substrates
  3. Which Includestipranavir

We sort drugs into categories. tipranavir is in our Cytochrome P450 2D6 (CYP2D6) Substrates category, and Terminalia interacts with every drug in it, so this interaction applies to tipranavir.

Interaction Details Explained

Theoretically, use of Terminalia arjuna may increase the levels and clinical effects of CYP2D6 substrates.
In vitro research shows that Terminalia arjuna extract inhibits CYP2D6 enzymes and reduces CYP2D6 substrate metabolism.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Terminalia + Cytochrome P450 2D6 (CYP2D6) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the gist with tipranavir (Aptivus) and Terminalia. The concern on file is that Terminalia arjuna may block a liver enzyme called CYP2D6, which can let drugs that depend on it build up in your blood. In theory, higher tipranavir levels could mean more side effects like nausea, stomach upset, diarrhea, or liver strain.

That said, I want to be honest about the evidence. This comes only from lab (test tube) studies, not from real people, so it's quite uncertain. Tipranavir also isn't mainly handled by CYP2D6, so any real effect may be small. Still, HIV therapy is too important to gamble with. Before adding Terminalia, please check with your pharmacist or doctor first.

Still have a question about this interaction?

Contact Dr. Brian directly

References 1 source behind this record

  1. Varghese A, Savai J, Pandita N, Gaud RS. In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin, and arjungenin on CYP3A4, CYP2D6, and CYP2C9 enzyme activity in human liver microsomes. Toxicology Reports. 2015(2):806-16. PubMed
Moderate Interaction 2 of 3

Terminalia With Cytochrome P450 2C9 (CYP2C9) Substrates

tipranavir is also in our Cytochrome P450 2C9 (CYP2C9) Substrates category.

Interaction Details Explained

Theoretically, use of Terminalia arjuna may increase the levels and clinical effects of CYP2C9 substrates.
In vitro research shows that Terminalia arjuna extract inhibits CYP2C9 enzymes and reduces CYP2C9 substrate metabolism.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Terminalia + Cytochrome P450 2C9 (CYP2C9) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the idea behind this pairing. Lab studies suggest Terminalia arjuna may slow down a liver enzyme called CYP2C9. Tipranavir (Aptivus) is partly handled by that enzyme and is an active drug, not a prodrug, so blocking the enzyme could let a bit more of it build up in your blood. In theory, that might mean stronger effects and a higher chance of side effects like nausea, stomach upset, tiredness, or rash.

The honest part: this warning comes only from test-tube research, not from people, so it's theoretical and may not happen at all. Still, HIV therapy is too important to gamble with. Please don't start or stop anything on your own. Check with your pharmacist or HIV doctor first so they can keep your treatment working safely.

Still have a question about this interaction?

Contact Dr. Brian directly

References 1 source behind this record

  1. Varghese A, Savai J, Pandita N, Gaud RS. In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin, and arjungenin on CYP3A4, CYP2D6, and CYP2C9 enzyme activity in human liver microsomes. Toxicology Reports. 2015(2):806-16. PubMed
Moderate Interaction 3 of 3

Terminalia With Cytochrome P450 3A4 (CYP3A4) Substrates

tipranavir is also in our Cytochrome P450 3A4 (CYP3A4) Substrates category.

Interaction Details Explained

Theoretically, use of Terminalia arjuna may increase the levels and clinical effects of CYP3A4 substrates.
In vitro research shows that Terminalia arjuna extract inhibits CYP3A4 enzymes and reduces CYP3A4 substrate metabolism.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Terminalia + Cytochrome P450 3A4 (CYP3A4) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the simple version: your body uses an enzyme called CYP3A4 to help break down tipranavir (Aptivus). Lab studies suggest that Terminalia arjuna may slow that enzyme down a bit. In theory, that could let tipranavir build up a little higher than usual, which might mean more of the drug's typical side effects, like nausea, stomach upset, diarrhea, tiredness, or changes in your liver tests.

I want to be honest about the strength of this, though. This concern comes only from test-tube research, not from studies in real people, so it's more theoretical than proven. Tipranavir is also an important HIV medicine you don't want to mess with, so please don't start or stop anything on your own. Just run the Terminalia idea by your pharmacist or HIV doctor first.

Still have a question about this interaction?

Contact Dr. Brian directly

References 1 source behind this record

  1. Varghese A, Savai J, Pandita N, Gaud RS. In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin, and arjungenin on CYP3A4, CYP2D6, and CYP2C9 enzyme activity in human liver microsomes. Toxicology Reports. 2015(2):806-16. PubMed
Know someone taking this combination? Share

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Terminalia Also Interacts With Other Medications

Besides tipranavir, Terminalia has 934 moderate known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Terminalia

Covers the 2,830 medications we’ve checked against Terminalia. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With tipranavir

Take other supplements too? 217 supplements have a documented interaction with tipranavir, each explained on its page.

By severity: 3 major, 168 moderate and 46 minor.

The Most Serious There Right Now:

Open the tipranavir interaction pageEvery supplement checked against tipranavir, ranked by severity
One More Smart Check

Taking Terminalia as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Terminalia. We have broken down 306 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against tipranavir:

Get to Know Each One

About Terminalia and tipranavir

Supplement

About Terminalia

Terminalia

Terminalia is a group of traditional Ayurvedic tree species (most notably Terminalia arjuna) used for heart, digestive, and general wellness purposes. Some small studies suggest possible benefits for heart and cholesterol health, but the evidence is limited and not strong enough to recommend it as a treatment. Talk to your pharmacist or doctor before using it, especially if you have a heart condition.

Full Terminalia guide: uses, dosage, safety and every interaction
Medication

About Tipranavir

Brand name: Aptivus

Aptivus (tipranavir) capsules, taken together with ritonavir, are used with other HIV medicines to treat HIV-1 infection. They are for adults and children weighing 36 kg or more who have already been treated and whose virus is resistant to more than one protease inhibitor.

Tipranavir: uses, dosage and side effects Tipranavir: interactions with other drugs Taking more than these two? Check Terminalia and Tipranavir with everything else you take Tipranavir NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Terminalia and tipranavir

Other drugs in the category this interaction applies to, and other supplements people check with tipranavir.

Moderate

Also in Our Cytochrome P450 2D6 (CYP2D6) Substrates Category

Terminalia interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

176 more in this category are on the Terminalia interactions list.

Moderate

Also in Our Cytochrome P450 2C9 (CYP2C9) Substrates Category

Terminalia interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

95 more in this category are on the Terminalia interactions list.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Substrates Category

Terminalia interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

384 more in this category are on the Terminalia interactions list.

Other Supplements With tipranavir

The most serious documented interactions with tipranavir first, then supplements with none on record, the most looked-up leading.

Show all 27 supplementsShow fewer
Keep Checking

Other Drugs & Terminalia

Browse every other medication we’ve checked against Terminalia — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
934Moderate
0Minor
1,895No known interaction
Moderate

Moderate: 934 interactions

Showing 60 of 934 moderate interactions — see all 934 on the Terminalia page.

No Interaction 1,895 drugs checked — show the list
How Much People Look This Up

Where Terminalia and tipranavir Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Terminalia
Top 10%

#132 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication tipranavir
Top half

#1,375 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Terminalia and tipranavir Together: Common Questions

Can you take Terminalia with tipranavir?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Terminalia with Aptivus?
Aptivus is a brand name of tipranavir, so the answer is the same as for tipranavir. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Aptivus too.
Why are there 3 interaction records for Terminalia and tipranavir?
We file interactions under single medicines and under categories of medicines that share an effect. tipranavir is named in, or belongs to, 3 of the categories we list for Terminalia, so 3 records apply. They can describe the same effect, so they are not 3 separate risks. We list every one so nothing is missed, and the most serious one sets the overall rating.
How serious is the Terminalia and tipranavir interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Terminalia and tipranavir?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.